Mw Unity's Stock Becomes The Latest Victim Of Google's Ai Ambitions

Earnings season continues, below we highlight companies expected to report earnings the next trading day so you can prepare for the action. Leading the charge on Monday are several market heavyweights including Palantir Technologies, NXP Semiconductors, Walt Disney, IDEXX Laboratories, and Simon Property Group, offering investors a diverse mix of tech, entertainment, real estate, and industrial sectors to monitor.

Earnings Before the Open

• Alliance Resource (ARLP) - EPS estimate: $0.624, Revenue estimate: $555.1M

• Delphi Automotive (APTV) - EPS estimate: $1.84, Revenue estimate: $5.09B

• TDK Corp (TTDKY) - EPS estimate: $0.2123, Revenue estimate: $3.96B

• Julius Baer Group Ltd (JBAXY) - EPS estimate: $0.5777, Revenue estimate: None

• Hess Midstream Partners LP (HESM) - EPS estimate: $0.7198, Revenue estimate: $417.05M

• IDEXX Laboratories (IDXX) - EPS estimate: $2.93, Revenue estimate: $1.07B

• Perkinelmer (RVTY) - EPS estimate: $1.55, Revenue estimate: $758.53M

• Twist Bioscience Corporation (TWST) - EPS estimate: -$0.428, Revenue estimate: $100.72M

• Tyson Foods (TSN) - EPS estimate: $0.9268, Revenue estimate: $14B

• NAPCO Security Technologies (NSSC) - EPS estimate: $0.3203, Revenue estimate: $47.8M

• Disney (DIS) - EPS estimate: $1.57, Revenue estimate: $25.62B

Earnings After the Close

• Mgic Inv (MTG) - EPS estimate: $0.7528, Revenue estimate: $308.19M

• Woodward (WWD) - EPS estimate: $1.66, Revenue estimate: $890.37M

• Kforce (KFRC) - EPS estimate: $0.4689, Revenue estimate: $328.79M

• Flexsteel Industries (FLXS) - EPS estimate: $0.79, Revenue estimate: $107.51M

• NewJersey Resources Corp (NJR) - EPS estimate: $1.01, Revenue estimate: $549.2M

• HCP Inc (DOC) - EPS estimate: $0.0687, Revenue estimate: $691.7M

• DaVita Inc (DVA) - EPS estimate: $3.24, Revenue estimate: $3.51B

• Palantir Technologies Inc (PLTR) - EPS estimate: $0.2297, Revenue estimate: $1.32B

• Two Harbors Investment Corp (TWO) - EPS estimate: $0.3694, Revenue estimate: -$9.15M

• Simon Prop Grp (SPG) - EPS estimate: $1.84, Revenue estimate: $1.49B

• Rambus Inc (RMBS) - EPS estimate: $0.68, Revenue estimate: $188.21M

• Capital Southwest (CSWC) - EPS estimate: $0.574, Revenue estimate: $58.01M

• NXP Semiconductors (NXPI) - EPS estimate: $3.3, Revenue estimate: $3.3B

• Teradyne Inc (TER) - EPS estimate: $1.36, Revenue estimate: $969.33M

• Ashland Inc (ASH) - EPS estimate: $0.2327, Revenue estimate: $402.05M

• Ono Pharmaceutical Co Ltd (OPHLY) - EPS estimate: $0.0908, Revenue estimate: $830.2M

• Fabrinet (FN) - EPS estimate: $3.25, Revenue estimate: $1.08B

Be sure to check back daily for updates and insights into the earnings season and real-time results at Investing.com’s Earnings Calendar and Headlines section. Do you want to trade the earnings of the biggest companies like a pro? Then get InvestingPro now and access over 1000 metrics that will give you a significant advantage in the shark tank that is Wall Street. Click here.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

As traders approach another pivotal day for financial markets, a series of crucial decisions and economic data releases that could sway market dynamics are expected on Monday, February 2, 2026. The manufacturing sector will be in focus with the release of Manufacturing PMI and ISM Manufacturing PMI data, providing key insights into the health of U.S. industrial activity. These reports are particularly significant as they offer early signals about broader economic trends and could influence market sentiment across various asset classes.

Major Economic Events to Watch

• 9:45 AM ET - Manufacturing PMI: This purchasing managers’ index measures manufacturing sector activity, with a forecast of 51.9 compared to the previous 51.8. Readings above 50 indicate expansion, making this a key barometer of industrial health.

• 10:00 AM ET - ISM Manufacturing PMI: This comprehensive index from the Institute of Supply Management surveys purchasing executives across 400+ industrial companies, with the previous reading at 47.9. The report provides detailed insights into new orders, production, employment, and other critical manufacturing indicators.

Other Important Economic Events to Watch

• 5:00 AM ET - OPEC Meeting: Representatives from 13 oil-producing nations will discuss energy markets and production quotas, potentially impacting global oil prices and energy stocks.

• 10:00 AM ET - ISM Manufacturing Employment: This component of the ISM report focuses specifically on hiring trends in the manufacturing sector, with the previous reading at 44.9, indicating contraction in manufacturing employment.

• 10:00 AM ET - ISM Manufacturing Prices: This inflation indicator tracks the prices paid by manufacturers for inputs, with the previous reading at 58.5, suggesting significant price pressures in the supply chain.

• 11:30 AM ET - Atlanta Fed GDPNow: This real-time GDP growth estimate is forecast at 4.2%, unchanged from the previous reading, offering insights into current-quarter economic performance.

• 12:30 PM ET - FOMC Member Bostic Speaks: Atlanta Fed President Raphael Bostic’s remarks will be closely monitored for clues about the Federal Reserve’s monetary policy outlook.

Other Economic Events to Watch

• 10:00 AM ET - ISM Manufacturing New Orders Index: This forward-looking component of the ISM report indicates future production levels, with the previous reading at 47.7.

• 11:30 AM ET - 3-Month Bill Auction: The U.S. Treasury will auction short-term government debt, with the previous auction yielding 3.580%.

• 11:30 AM ET - 6-Month Bill Auction: This Treasury auction of medium-term bills had a previous yield of 3.525%, providing insights into investor demand for government securities.

• 2:00 PM ET - Loan Officer Survey: This Federal Reserve survey of domestic and foreign banks operating in the U.S. examines lending standards and loan demand, offering valuable insights into credit conditions.

For further information and the latest updates, please refer to our Economic Calendar, here.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Colombia’s central bank raised its interest rate by 100 basis points to 10.25% on Friday, marking the first increase since April 2023.

The decision, backed by a majority of the seven-member board, came as a surprise to market analysts who had largely expected a smaller adjustment.

In a recent poll of 26 analysts, most had predicted a 50 basis point increase, while only two had forecast no change at all. The actual increase was double what most market participants had anticipated.

The central bank cited uncertainty over public finances and intensifying inflationary pressures as key factors behind the larger-than-expected rate hike.

This represents the first upward adjustment to Colombia’s benchmark interest rate in nearly three years, signaling a shift in monetary policy direction for the South American nation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Moody’s Ratings has upgraded Hyundai Glovis Co., Ltd.’s issuer rating to A3 from Baa1 and changed the outlook to stable from positive, the ratings agency announced Friday.

The upgrade reflects Hyundai Glovis’ sustained improvement in profitability and low debt leverage, supported by conservative financial management, according to Mic Kang, a Moody’s Vice President and Senior Credit Officer.

Hyundai Glovis reported an operating margin improvement to 7.0% in 2025 from 6.2% in 2024. Moody’s expects this ratio to remain at similar levels over the next 12-18 months.

The company’s performance improvement is primarily driven by stronger results in its pure car and truck carriers business, benefiting from solid demand from automobile companies, a shift in fleet mix toward long-term chartered vessels, increasing revenue from non-captive clients, and higher freight rates for captive customers.

The company’s adjusted debt/EBITDA improved to approximately 1.4x in 2025 from 1.8x in 2024, driven by increased earnings and reduced debt. Moody’s projects this ratio will remain in the 1.4x-1.5x range over the next 12-18 months, supported by the company’s ability to generate free cash flow and its disciplined financial management.

Operating cash flow is expected to be sufficient to cover higher capital spending for fleet expansion and other investments, as well as shareholder returns. The company maintains a net cash position of around KRW0.5 trillion, which supports its A3 rating.

The A3 rating is underpinned by Hyundai Glovis’ operational stability, which reflects large captive demand from Hyundai Motor group affiliates, including Hyundai Motor Company (A3 stable) and Kia Corporation (A3 stable), and limited exposure to market risks.

Moody’s noted that Hyundai Glovis faces customer concentration in the cyclical auto industry and exposure to the capital-intensive and cyclical shipping business.

Regarding environmental, social, and governance factors, Hyundai Glovis faces environmental and social risks similar to its transport peers. The company’s prudent financial management offsets its exposure to potential regulatory scrutiny related to its organizational structure.

The stable outlook reflects Moody’s expectation that Hyundai Glovis will maintain steady profitability and low financial leverage over the next 12-18 months.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- KeyBanc Capital Markets has identified three standout performers in the medical technology sector, with LivaNova PLC leading the pack, followed by ICU Medical Inc and Steris PLC. These companies have received favorable ratings based on their market positioning and growth potential in specialized healthcare segments.

See how Wall Street analysts are valuing these stocks with InvestingPro’s full ratings, price targets, and earnings models -

LivaNova PLC tops the list with an Overweight rating and a price target of $81. The company operates through two main segments: Cardiopulmonary and Neuromodulation. In its Cardiopulmonary division, LivaNova specializes in Heart-Lung Machines (HLMs), oxygenators, and related accessories essential for cardiac surgeries. The Neuromodulation segment focuses on Vagus Nerve Stimulation (VNS) technology, which offers treatments for Drug-Resistant Epilepsy and Depression. This dual focus positions LivaNova as a leader in both critical cardiac care and neurological treatment markets.

Stifel recently raised its price target on LivaNova to $70, citing strong growth in its Cardiopulmonary business. The company also announced that U.S. Medicare will significantly increase reimbursement rates for its VNS Therapy for epilepsy starting in 2026.

ICU Medical Inc ranks second with an Overweight rating and a price target of $175. The company manufactures and markets products crucial for infusion therapy, vascular access, oncology, and vital care applications. Its product portfolio includes infusion systems and consumables, IV solutions, and closed-system transfer devices designed to enhance patient safety. ICU Medical significantly expanded its market presence through the strategic acquisition of Smiths Medical in late 2021, strengthening its position in the medical device market.

In recent developments, ICU Medical reported third-quarter revenue and earnings that surpassed analyst expectations. Following the results, the company raised its full-year guidance for both EBITDA and adjusted EPS, and Piper Sandler increased its price target on the company to $172.

Steris PLC rounds out the top three with an Overweight rating and a price target of $291. The company provides a comprehensive range of sterilization and infection prevention solutions for healthcare facilities and life sciences companies. Steris offers capital equipment including sterilizers, washers, and operating room suite components, alongside consumables and specialized services such as outsourced sterilization and instrument repair. This diverse product and service mix creates multiple revenue streams across different healthcare segments.

Steris PLC announced second-quarter fiscal 2025 results, reporting an earnings per share that beat analyst forecasts, though revenue fell short of expectations. The company also declared a quarterly dividend of $0.63 per share.

KeyBanc’s analysis highlights these three companies as particularly well-positioned within the competitive MedTech landscape, each addressing critical needs in healthcare delivery and patient safety with specialized technologies and services.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.